Follitropin delta in a long hormone-suppression IVF cycle
Part of Women’s health & pregnancy clinical trials.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 44 years old.
- You must have had an AMH blood test in the last year showing a result between 0.3 and 4.9 ng/ml.
- This must be your first or second try at IVF or ICSI using sperm from a partner or donor.
- You cannot have taken birth control pills (with estrogen and progestin) in the past month.
- You cannot have PCOS that causes irregular ovulation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.
This study tests a different type of fertility medication to help women who had fewer than 9 eggs retrieved in a previous IVF cycle. It's designed for women between 18 and 40 with a specific hormone profile, and aims to improve egg collection results.
This trial tests whether adding a hormone (r-hLH) to standard ovarian stimulation medicine helps women aged 35 to 40 produce more eggs during IVF. It may be a good option if you have lower ovarian reserve and are starting your first or second IVF cycle.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.